Are Caprolactam Chemicals Ltd latest results good or bad?
2026-05-31 19:20:41Caprolactam Chemicals Ltd has reported its financial results for the quarter ended March 2026, showcasing a notable operational turnaround. The company achieved net sales of ₹3.07 crores, reflecting a year-on-year growth of 90.68% and a quarter-on-quarter increase of 19.92%. This significant revenue growth indicates a recovery trajectory following previous challenges. The net profit for the quarter stood at ₹0.84 crores, marking a return to profitability compared to a loss in the same quarter last year. This represents a substantial improvement in the company's financial health. The operating margin reached 54.07%, the highest in eight quarters, demonstrating effective cost management and operational efficiency. Additionally, the profit after tax (PAT) margin improved to 27.36%, a stark contrast to the negative margin reported in the previous year. Despite these positive operational metrics, Caprolactam C...
Read full news article
Caprolactam Chemicals Q4 FY26: Turnaround Gains Momentum but Valuation Concerns Persist
2026-05-30 23:47:51Caprolactam Chemicals Ltd., a micro-cap commodity chemicals manufacturer with a market capitalisation of ₹22.00 crores, reported a remarkable turnaround in Q4 FY26 (January-March 2026), posting net profit of ₹0.84 crores compared to a loss of ₹0.45 crores in the same quarter last year. The stock has responded positively to the operational recovery, gaining 18.60% over the past year, though it remains 39.46% below its 52-week high of ₹81.00. At the current market price of ₹49.04, the company trades at a concerning valuation of 2,254 times trailing twelve-month earnings, raising serious questions about sustainability despite improved fundamentals.
Read full news articleAre Caprolactam Chemicals Ltd latest results good or bad?
2026-05-30 19:43:41Caprolactam Chemicals Ltd's latest financial results for Q2 FY26 present a mixed picture, highlighting both revenue growth and significant challenges in profitability. The company reported net sales of ₹2.36 crores, which reflects a sequential decline of 7.81% from the previous quarter but shows a year-on-year growth of 38.01% compared to ₹1.71 crores in the same quarter last year. This indicates that while the company is experiencing some demand traction, it is also facing potential softness in order flows or seasonal factors affecting sales. On the profitability front, net profit for the quarter was ₹0.13 crores, marking a substantial quarter-on-quarter decline of 63.89% from ₹0.36 crores in Q1 FY26. However, this represents a notable improvement from the ₹0.04 crores profit recorded in the same quarter last year. The operating margin also contracted significantly to 27.97%, down from 40.63% in the previ...
Read full news article
Caprolactam Chemicals Ltd Downgraded to Strong Sell Amid Technical and Fundamental Weaknesses
2026-05-28 08:13:28Caprolactam Chemicals Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 27 May 2026, driven primarily by deteriorating technical indicators and stagnant financial performance. Despite a modest one-year stock return outperforming the broader market, the company’s weak fundamentals and bearish technical trends have raised concerns among analysts and investors alike.
Read full news article
Caprolactam Chemicals Ltd is Rated Sell
2026-05-15 10:10:02Caprolactam Chemicals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Caprolactam Chemicals Ltd Valuation Shifts Signal Price Attractiveness Concerns
2026-04-22 08:00:28Caprolactam Chemicals Ltd, a micro-cap player in the commodity chemicals sector, has witnessed a significant shift in its valuation parameters, raising questions about its price attractiveness amid a volatile market backdrop. The company’s price-to-earnings (P/E) ratio has surged to an extraordinary 2,688.7, while its price-to-book value (P/BV) stands at 5.05, marking a transition from fair to expensive valuation territory. This article analyses these valuation changes in the context of historical trends, peer comparisons, and broader market performance to provide investors with a comprehensive perspective.
Read full news article
Caprolactam Chemicals Ltd: Valuation Shifts Signal Changing Price Attractiveness
2026-04-15 08:00:44Caprolactam Chemicals Ltd has experienced a notable shift in its valuation parameters, moving from an attractive to a fair rating despite its sky-high price-to-earnings (P/E) ratio. This transition reflects a complex interplay of market sentiment, financial metrics, and sector comparisons, raising important considerations for investors navigating the commodity chemicals space.
Read full news article
Caprolactam Chemicals Ltd Valuation Shifts Signal Renewed Price Attractiveness
2026-04-06 08:00:23Caprolactam Chemicals Ltd, a micro-cap player in the commodity chemicals sector, has witnessed a notable shift in its valuation parameters, moving from a previously fair to an attractive valuation grade. Despite a challenging market environment reflected in its recent share price decline, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a potential re-rating opportunity relative to its historical and peer benchmarks.
Read full news article
Caprolactam Chemicals Ltd: Valuation Shift Signals Renewed Price Attractiveness
2026-03-17 08:00:22Caprolactam Chemicals Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade despite a significant decline in its share price. This change reflects evolving market perceptions amid mixed financial metrics and peer comparisons within the commodity chemicals sector.
Read full news articleAnnouncement under Regulation 30 (LODR)-Newspaper Publication
01-Jun-2026 | Source : BSENewspaper Advertisement of the Audited Financial Result for Quarter ended 31 March 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On Saturday 30 May 2026
30-May-2026 | Source : BSEOutcome of the Board Meeting held on Saturday 30 May 2026
Board Meeting Intimation for Prior Intimation Of Board Meeting To Consider Audited Financial Results For Quarter And Financial Year Ended March 31 2026
06-May-2026 | Source : BSECaprolactam Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Prior Intimation of Board Meeting to consider Audited Financial Results for quarter and financial year ended March 31 2026
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






